No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antiviral Agents / chemistry
-
Antiviral Agents / pharmacology*
-
Betacoronavirus / drug effects*
-
Betacoronavirus / pathogenicity
-
Biological Products / chemistry
-
Biological Products / pharmacology
-
Bufanolides / chemistry
-
Bufanolides / pharmacology
-
COVID-19
-
Cardiac Glycosides / chemistry
-
Cardiac Glycosides / pharmacology*
-
Cell Survival / drug effects
-
Chlorocebus aethiops
-
Chloroquine / chemistry
-
Chloroquine / pharmacology
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / virology
-
Digoxin / chemistry
-
Digoxin / pharmacology
-
Gene Expression Regulation / drug effects*
-
High-Throughput Screening Assays
-
Host-Pathogen Interactions / drug effects*
-
Host-Pathogen Interactions / genetics
-
Humans
-
Janus Kinases / antagonists & inhibitors
-
Janus Kinases / genetics
-
Janus Kinases / metabolism
-
Mitogen-Activated Protein Kinases / antagonists & inhibitors
-
Mitogen-Activated Protein Kinases / genetics
-
Mitogen-Activated Protein Kinases / metabolism
-
NF-E2-Related Factor 2 / antagonists & inhibitors
-
NF-E2-Related Factor 2 / genetics
-
NF-E2-Related Factor 2 / metabolism
-
NF-kappa B / antagonists & inhibitors
-
NF-kappa B / genetics
-
NF-kappa B / metabolism
-
Pandemics
-
Phenanthrenes / chemistry
-
Phenanthrenes / pharmacology
-
Pneumonia, Viral / drug therapy
-
Pneumonia, Viral / virology
-
SARS-CoV-2
-
Signal Transduction
-
Sodium-Potassium-Exchanging ATPase / antagonists & inhibitors
-
Sodium-Potassium-Exchanging ATPase / genetics
-
Sodium-Potassium-Exchanging ATPase / metabolism
-
Vero Cells
-
Virus Replication / drug effects
Substances
-
Antiviral Agents
-
Biological Products
-
Bufanolides
-
Cardiac Glycosides
-
NF-E2-Related Factor 2
-
NF-kappa B
-
Phenanthrenes
-
cryptotanshinone
-
Digoxin
-
Chloroquine
-
Janus Kinases
-
Mitogen-Activated Protein Kinases
-
Sodium-Potassium-Exchanging ATPase
-
bufalin